Ivo Boskoski
Ivo Boskoski, MD, PhD is an expert in Medical imaging at Agostino Gemelli University Polyclinic (Italy). As of October 2026, ScienceLeadR ranks Ivo Boskoski in the top 1% of experts worldwide for Endoscopy, Obesity and Overweight. Ivo Boskoski has authored 459 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 9 of them ongoing. SLR score: 1,719 (community average: 125). How the SLR is computed.
LeadR Profile
Medical imaging
Subspecialties: Gastroenterology - Surgery - Hepatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
I am a Gastroenterologist with over 20 years of experience in advanced endoscopy, academic teaching, and clinical research. After graduating in Medicine from the University of Perugia (2005), I completed my residency in Gastroenterology at Campus Bio-Medico University of Rome (2009) and earned a PhD in Endoscopic Treatment of Obesity at the Catholic University of Rome (2013).
Currently, I serve as Associate Professor of Gastroenterology at the Catholic University of Rome and as Consultant Gastroenterologist at Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
My clinical and research focus includes:
Biliopancreatic endoscopy (ERCP) and cholangioscopy
Management of biliopancreatic complications and malignancies
Endoscopic treatment of chronic pancreatitis and postoperative complications
Bariatric endoscopy (ESG, bypass revisions, treatment of complications)
Regenerative endoscopy and innovative therapeutic approaches
I am passionate about education and innovation in endoscopy. Since 2009, I have been an Instructor and Faculty Member at the European Endoscopy Training Center (EETC) and IRCAD France, and I co-invented the Boškoski-Costamagna ERCP Training Model, widely used for hands-on training worldwide.
I also serve as Secretary and Advisory Board Member of the Centre for Endoscopic Research Therapeutics and Training (CERTT), and I was a Governing Board Member of the European Society of Gastrointestinal Endoscopy (ESGE) for the 2022-2025 term.
Author of numerous peer-reviewed publications, book chapters, and abstracts, I regularly lecture at national and international conferences and participate in live endoscopy workshops.
Organizations
Career arc: 2007 - 2026
Number : 459
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
9 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Endoscopic Injection of Autologous Fat Derived Cells (SVF) for Adults With Refractory Gastroesophageal Reflux Disease (GERD) (The GERD REVIVE Pilot Study) NCT07638423 — injections, pilot projects, cells, pilots, safety, point-of-care systems, esophagogastric junction, digestion, endoscopy, therapeutics, tissues, gastroesophageal reflux, needles, adipose tissue | N/A | Not yet recruiting | 2026 |
| Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells NCT07344324 — diabetes mellitus, injections, pilot projects, cells, pilots, safety, insulin, microscopy, electron, scanning transmission, deep sedation, stem cells, mesenchymal stem cells, biopsy, obesity, therapeutics, tissues, needles, adipose tissue, diabetes mellitus, type 2 | N/A | Not yet recruiting | 2026 |
| Endoscopic Injection of Autologous Activated and Emulsified Fat in Chronic Fistulas of the Gastrointestinal Tract and Pelvic Organs NCT06930079 — injections, cells, quality of life, fistula, microscopy, electron, scanning transmission, communication, gastrointestinal tract, therapeutics, tissues, adipose tissue | N/A | Recruiting | 2025 |
| Effect of proton pump inhibitors on the structural integrity of endoscopic sleeve gastroplasty a single centre open label randomized controlled pilot clinical trial 2024-517679-18-00 — gastroplasty, pilots, proton pump inhibitors, obesity, proton pumps | Phase 4 | Recruiting | 2024 |
| The ESG Integrity Study Effect of Proton Pump Inhibitors on the Structural Integrity of Endoscopic Sleeve Gastroplasty NCT06283381 — gastroplasty, pilots, administration, oral, esomeprazole, tablets, proton pump inhibitors, obesity, proton pumps | Phase 4 | Recruiting | 2024 |
LeadR Networks
Main global connection map